XCSEMONSO
Market cap3mUSD
Dec 23, Last price
0.36DKK
1D
7.14%
1Q
-40.98%
IPO
-94.46%
Name
Monsenso A/S
Chart & Performance
P/E
—
P/S
2.49
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
56.48%
Rev. gr., 5y
5.11%
Revenues
10m
+54.90%
Net income
-5m
L-31.79%
CFO
3m
P
Earnings
Apr 29, 2025
Profile
Monsenso A/S develops and sells digital health solution for the treatment of mental disorders. It offers Monsenso app for individuals that help them in the areas of self-assessments and questionnaires, sensor data collection from phones and wearables, reminders on medication and sessions, visualizations and motivational feedback, and psychoeducation and cognitive behavioral therapy; and app for carers that help them in the areas of self-assessments, questionnaires, psychoeducation, and a range of learning tools. The company also provides clinical web portal for clinicians enable users for the visualization of patient data, patient dashboard, historical overview, correlation analysis, messaging, shared decision-making, and notes/medical record keeping; and data analytics for clinicians for historical aggregation of health and behavioral data, statistical descriptors, correlation between behavioral data and illness progression, pattern analysis, predictive analytics and mood forecasting, and risk assessment. It serves patients, clinicians, healthcare systems and researchers, and carers. Monsenso A/S was incorporated in 2013 and is based in Copenhagen, Denmark.
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 9,624 54.90% | 6,213 -13.02% | 7,143 -21.19% | ||||||
Cost of revenue | 15,423 | 15,029 | 16,164 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | (5,799) | (8,816) | (9,021) | ||||||
NOPBT Margin | |||||||||
Operating Taxes | (544) | (1,100) | (1,183) | ||||||
Tax Rate | |||||||||
NOPAT | (5,255) | (7,716) | (7,838) | ||||||
Net income | (5,357) -31.79% | (7,854) -3.67% | (8,153) 72.99% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 1,475 | 1,167 | 10,941 | ||||||
BB yield | -15.90% | -9.71% | -36.98% | ||||||
| Debt | |||||||||
Debt current | (868) | (1,255) | |||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | 536 | 344 | |||||||
Net debt | (1,812) | (1,554) | (9,164) | ||||||
| Cash flow | |||||||||
Cash from operating activities | 2,552 | (3,390) | (4,383) | ||||||
CAPEX | (99) | (5,000) | (11,256) | ||||||
Cash from investing activities | (2,787) | (4,970) | (11,256) | ||||||
Cash from financing activities | 1,475 | 1,167 | 10,941 | ||||||
FCF | (4,294) | (5,733) | (7,826) | ||||||
| Balance | |||||||||
Cash | 1,812 | 572 | 7,765 | ||||||
Long term investments | 114 | 144 | |||||||
Excess cash | 1,331 | 375 | 7,552 | ||||||
Stockholders' equity | 10,873 | 14,755 | 21,442 | ||||||
Invested Capital | 10,078 | 13,512 | 12,635 | ||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 32,102 | 27,319 | 24,653 | ||||||
Price | 0.29 -34.32% | 0.44 -63.33% | 1.20 -90.28% | ||||||
Market cap | 9,277 -22.82% | 12,020 -59.37% | 29,584 -85.07% | ||||||
EV | 7,465 | 10,466 | 20,420 | ||||||
EBITDA | (1,395) | (3,997) | (5,102) | ||||||
EV/EBITDA | |||||||||
Interest | 112 | 138 | 317 | ||||||
Interest/NOPBT | |||||||||